People

Frederik Rombouts

linkedin.com

Frederik Rombouts is a medicinal-chemistry and drug-discovery researcher associated with Augustine Therapeutics. The company identified him as Head of Medicinal Chemistry and principal investigator of its ALS Association-funded project in February2024, and as Vice President, Head of Drug Discovery in a2025 public company post. The project examines next-generation HDAC6 inhibitors with peripheral-restricted or brain-penetrant properties in preclinical ALS studies. He is not listed in the current visible website leadership roster, so the dated published role is qualified.